HHLR Advisors’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-500,000
| Closed | -$2.41M | – | 69 |
|
|
2022
Q3 | $2.41M | Hold |
500,000
| – | – | 0.06% | 51 |
|
|
2022
Q2 | $3.98M | Hold |
500,000
| – | – | 0.09% | 49 |
|
|
2022
Q1 | $7.35M | Hold |
500,000
| – | – | 0.15% | 37 |
|
|
2021
Q4 | $10.1M | Hold |
500,000
| – | – | 0.16% | 49 |
|
|
2021
Q3 | $13.6M | Hold |
500,000
| – | – | 0.18% | 56 |
|
|
2021
Q2 | $12.2M | Hold |
500,000
| – | – | 0.13% | 65 |
|
|
2021
Q1 | $12.2M | Hold |
500,000
| – | – | 0.12% | 58 |
|
|
2020
Q4 | $16M | Hold |
500,000
| – | – | 0.13% | 64 |
|
|
2020
Q3 | $16.5M | Hold |
500,000
| – | – | 0.12% | 51 |
|
|
2020
Q2 | $23.4M | Buy |
+500,000
| New | +$23.4M | 0.21% | 42 |
|